Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQVS6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,232
Award facts
- Contract value 100% obligated
- $6,231.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,231.60 to DMS Pharmaceutical Group Inc. on January 20, 2026, for the supply of Botox 200 Unit Vials with an ultimate completion date of February 10, 2026. This firm fixed-price delivery order was issued without a set-aside designation, allowing the woman-owned small business pharmaceutical wholesaler to compete openly in unrestricted federal procurement. DMS Pharmaceutical Group, headquartered in Park Ridge, Illinois, serves as a critical supplier within the Department of Defense's pharmaceutical supply chain, leveraging its extensive distribution capabilities to support military healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was established on November 13, 2025, with a $499.9 billion ceiling value through December 31, 2036. As a designated regional prime vendor contractor under the broader $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group is authorized to supply a comprehensive range of pharmaceutical products, biologics, and medical consumables to support recurring medical supply needs of military healthcare facilities worldwide. The company's established performance across numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FQVS6?
SPE2DR26FQVS6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FQVS6 worth?
The government has obligated $6,232 on SPE2DR26FQVS6.
Is contract SPE2DR26FQVS6 an order under another contract?
Yes. SPE2DR26FQVS6 is a delivery order under SPE2DR25D9247, an indefinite delivery contract.
Was contract SPE2DR26FQVS6 competed?
The extent of competition for SPE2DR26FQVS6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award